Literature DB >> 16556732

Identification of structural determinants for G protein-independent activation of mitogen-activated protein kinases in the seventh transmembrane domain of the angiotensin II type 1 receptor.

Daniel K Yee1, Aae Suzuki, Laiyi Luo, Steven J Fluharty.   

Abstract

Although the intrareceptor mechanisms whereby the angiotensin II (AngII) type 1 receptor activates phospholipase C (PLC) have been extensively investigated, analogous studies of signaling through mitogen-activated protein kinases (MAPK) have been lacking. We investigated MAPK activation and traditional G(q)/PLC signaling in transfected cells using AngII and the signaling selective agonist [Sar(1),Ile(4),Ile(8)] AngII (SII). SII stimulated MAPK without inositol trisphosphate (IP(3)) production and thereby stabilizes an activated receptor state linked to G protein-independent MAPK signaling. Using receptor mutagenesis, we focused on the seventh transmembrane domain and identified three key residues-Tyr(292), Phe(293), and Thr(287). At least three distinct activated states were revealed: 1) an AngII-stabilized state linked to G(q)/PLC signaling, 2) an AngII-stabilized state connected to G protein-independent MAPK activation, and 3) a SII-stabilized state associated with G protein-independent MAPK signaling. The mutant Y292F failed to exhibit AngII-induced IP(3) turnover yet remained capable of AngII-induced MAPK activation. SII failed to stimulate MAPK in Y292F-transfected cells. Thus, Tyr(292) is a key epitope for activated states 1 and 3 but not required for activated state 2. Although the F293L mutant retained normal AngII responses, it also showed an IP(3) response to SII, indicating that Phe(293) may be involved in constraining the receptor to its inactive state. Mutations of Thr(287) abolished all SII-induced signaling without affecting any AngII responses. Thr(287) therefore represents a key residue for a SII-stabilized activated state. Taken together, the data identified a novel structural requirement (Thr(287)) for the SII-stabilized activated state and redefined the mechanistic roles for Tyr(292) and Phe(293).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16556732     DOI: 10.1210/me.2006-0018

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  8 in total

Review 1.  Alan [corrected] N. Epstein award: Intracellular signaling and ingestive behaviors.

Authors:  Derek Daniels
Journal:  Physiol Behav       Date:  2010-03-25

Review 2.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

Review 3.  Beta-arrestins and heterotrimeric G-proteins: collaborators and competitors in signal transduction.

Authors:  K Defea
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

4.  Beta-arrestin-mediated signaling regulates protein synthesis.

Authors:  Scott M DeWire; Jihee Kim; Erin J Whalen; Seungkirl Ahn; Minyong Chen; Robert J Lefkowitz
Journal:  J Biol Chem       Date:  2008-02-14       Impact factor: 5.157

5.  Mechanism of Hormone Peptide Activation of a GPCR: Angiotensin II Activated State of AT1R Initiated by van der Waals Attraction.

Authors:  Khuraijam Dhanachandra Singh; Hamiyet Unal; Russell Desnoyer; Sadashiva S Karnik
Journal:  J Chem Inf Model       Date:  2019-01-16       Impact factor: 4.956

6.  Selective inhibition of angiotensin receptor signaling through Erk1/2 pathway by a novel peptide.

Authors:  Jun Liu; Gina L C Yosten; Hong Ji; Dan Zhang; Wei Zheng; Robert C Speth; Willis K Samson; Kathryn Sandberg
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-02-12       Impact factor: 3.619

7.  Biased signaling of the angiotensin II type 1 receptor can be mediated through distinct mechanisms.

Authors:  Marie Mi Bonde; Jonas Tind Hansen; Samra Joke Sanni; Stig Haunsø; Steen Gammeltoft; Christina Lyngsø; Jakob Lerche Hansen
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

Review 8.  Type 1 angiotensin receptor pharmacology: signaling beyond G proteins.

Authors:  Cristina Oro; Hongwei Qian; Walter G Thomas
Journal:  Pharmacol Ther       Date:  2006-10-14       Impact factor: 12.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.